Drawing for Serial No. 88230292

USPTO serial 88230292

Serial No. 88230292

Reviewed by CopyMark Law Group

Reg. 5935386Status 705Registered
Filing date
Status date
Registration date
Dec 17, 2019
Examiner
THOMAS-RIGGS, LESLIE A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with Serial No. 88230292?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James A. Thomas

30 Hudson StreetFL 33-34Jersey City, NJ 07302

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for human use for the treatment of dermatological diseases, disorders and conditions; biologic preparations for medical and therapeutic purposes for the treatment of dermatological diseases, disorders and conditionsACTIVE—
042[ Scientific and technological services, namely, medical research, scientific research and analysis in the field of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials ]SECTION 8 - CANCELLED—
044[ Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions ]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 18, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 18, 2026C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 18, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 15, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Oct 28, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 28, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Oct 28, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 28, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 28, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 28, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 17, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 17, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 1, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 1, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 11, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 27, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 19, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 19, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 13, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 29, 2019ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Feb 22, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 16, 2019DOCKASSIGNED TO EXAMINER—
Jan 8, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 7, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 20, 2018AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Dec 20, 2018ALIEASSIGNED TO LIE—
Dec 18, 2018PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 18, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance